Oncology | Radiology Ultrasound deep learning radiomics and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma . May 9, 2024
Orthopedics | Radiology Exploring deep learning radiomics for classifying osteoporotic vertebral fractures in X-ray images. April 12, 2024
Oncology | Radiology Application of deep learning radiomics in oral squamous cell carcinoma-Extracting more information from medical images using advanced feature analysis. March 28, 2024
Breast Surgery | Oncology | Radiology Deep learning radiomics based prediction of axillary lymph node metastasis in breast cancer. March 13, 2024
Intensive Care Medicine | Radiology Deep learning radiomics on shear wave elastography and b-mode ultrasound videos of diaphragm for weaning outcome prediction. February 16, 2024
Radiology | Rheumatology Use of MRI-based deep learning radiomics to diagnose sacroiliitis related to axial spondyloarthritis. February 7, 2024
Oncology | Radiology Exploring non-invasive precision treatment in non-small cell lung cancer patients through deep learning radiomics across imaging features and molecular phenotypes. January 25, 2024
Oncology | Orthopedics | Radiology Fusion Radiomics-Based Prediction of Response to Neoadjuvant Chemotherapy for Osteosarcoma. December 27, 2023
Cancer Imaging | Oncology | Radiology Deep learning radiomics of multimodal ultrasound for classifying metastatic cervical lymphadenopathy into primary cancer sites: a feasibility study. December 5, 2023
Oncology | Radiology Prediction of sentinel lymph node metastasis in breast cancer by using deep learning radiomics based on ultrasound images. November 7, 2023
Oncology | Pathology | Radiology End-to-end deep learning radiomics: development and validation of a novel attention-based aggregate convolutional neural network to distinguish breast diffuse large B-cell lymphoma from breast invasive ductal carcinoma. October 23, 2023
Hematology | Oncology | Radiology CT-based deep learning radiomics and hematological biomarkers in the assessment of pathological complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma: A two-center study. October 15, 2023